Dr. Fabian Badtke , LL.M.

Practice Group Antitrust & Competition
Practice Group

Dr. Fabian Badtke advises national and international clients on all aspects of European and German Antitrust Law, including merger control and coordination of multijurisdictional filings, antitrust investigations (incl. e-Discovery & internal investigations), cartel damage claims and compliance-programmes (incl. e-Learning and webinars). Fabian has a particular industry know-how in the financial services sector, health care & life sciences, retail and media.

He is a Member of Studienvereinigung Kartellrecht [Antitrust Research Association]. Fabian regularly publishes on current antitrust topics. He is founder and moderator of the Antitrust Law Group @XING, an online-community for competition law (Antitrust|XING).


  • German and European Competition Law
  • German and European Merger Control
  • European Law
  • Compliance and internal investigations


  • Legal studies at the universities of Potsdam, Cambridge, Great Britain (LL.M.) and at the Humboldt-University of Berlin
  • Teaching assistent at the Trinity College, School of Law, Dublin (Ireland)
  • Experience as a lawyer in a law firm specialised in medical law in Berlin
  • Karlheinz Quack Award 2008 for the best dissertation in Corporate law, Competition Law and Intellectual Property Rights, Faculty of Law, Humboldt-University, Berlin
  • With Noerr since 2007
  • Admitted to the Berlin Chamber of Lawyers since 2006


  • Fresenius/Helios on the acquisition of 40 hospitals and 13 medical care centres from Rhoen Klinikum
  • ABN AMRO on the acquisition of Credit Suisse's private banking business in Germany
  • Advice to a large German industrial company on internal compliance investigations
  • Gazprom on the acquisition Envacom’s power supply business
  • Air Berlin on the foundation of a joint venture with CCC
  • Ongoing comprehensive competition law advice to a large European retail chain


  • Frequently recommended for Antitrust (Juve 2016/2017)
  • Recommended consultant for healthcare antitrust (Juve 2016/2017)
  • Recognised as "Antitrust-Specialist of the future", Legal 500 (2014)
  • Frequently recognised and listed as "Cartel Law Expert", Germany’s "Handelsblatt" newspaper
  • In 2008, he was awarded with the Karlheinz Quack Award for the best dissertation in corporate law, competition law and intellectual property rights by Humboldt-University Berlin.




  • Member of Studienvereinigung Kartellrecht [Antitrust Research Association]

Selected Publications

  • Should the Acquisition of Non-controlling Minority Shareholdings be Treated as Concentrations? (with Rea Diamantatou), Journal of European Competition Law and Practice, 2016, Vol. 7, No. 1, p. 3 et seq.
  • Das Kartellrecht der Bankgeschäfte, in: Bankrecht, 4. issue 2014 (Carl Heymanns Verlag)
  • Kollektive Marktbeherrschung im Kraftstoffmarkt? (with Dr. Oliver Vahrenholt), in: Zeitschrift für Wettbewerbsrecht (ZWeR) 2012, pp. 272 et seq.
  • Die Bedeutung des Kartellrechts bei M&ATransaktionen, in: Kölner Schrift zum Wirtschaftsrecht (KSzW), 2011, pp. 418 et seq.
  • Das Kartellrecht und die aktuelle Debatte um die Laufzeitverlängerung von Atomkraftwerken – eine kritische Würdigung (mit Oliver Vahrenholt), in: Wettbewerb in Recht und Praxis (WRP) 2010, pp. 852 et seq.
  • Der "Rhön-Beschluss" des BGH – endlich Klarheit bei der Zusammenschlusskontrolle von Krankenhausfusionen?, in: Zeitschrift für das gesamte Krankenhausrecht (KHR) 2008, p. 141
  • Die Anwendbarkeit der deutschen und europäischen Fusionskontrolle auf Zusammenschlüsse von Krankenhäusern, 2008 (Nomos Verlag)
  • Die kartellrechtliche Bewertung des "AOK-Modells" beim Abschluss von Rabattverträgen, in: Wirtschaft und Wettbewerb (WuW) 2007, pp. 726 et seq.
  • Should the Acquisition of Non-controlling Minority Shareholdings be Treated as Concentrations? (with Rea Diamantatou), Journal of European Competition Law of Practice, 2016,Vol.7, No.1, p.3 ff.